A. D. Marco

Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance.

R. Cortese, G. Ciliberto, R. Laufer, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Identification of ciliary neurotrophic factor (CNTF) residues essential for leukemia inhibitory factor receptor binding and generation of CNTF receptor antagonists.

R. Laufer, G. Paonessa, A. Di Marco, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Determination of drug glucuronidation and UDP-glucuronosyltransferase selectivity using a 96-well non-HPLC radiometric assay Separation of glucuronide products. Oasis TM HLB 30mg solid phase 96 well extraction

R. Laufer, P. Carotenuto, Annalise Di Marco, 2005 .

Penetrating brain injury leads to activation of ciliary neurotrophic factor receptors

R. Laufer, A. MacLennan, N. Lee, 2005, Neuroscience Letters.

DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE

R. Laufer, F. Peláez, Manuel Sánchez, 2005, Drug Metabolism and Disposition.

Development of humanized mice for the study of hepatitis C virus infection.

P. Turrini, J. Padron, R. Laufer, 2006, Transplantation proceedings.

PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes.

A. Peier, A. Pocai, R. Laufer, 2012, Bioorganic & medicinal chemistry.